We subsequently focused on pancreatic ductal adenocarcinoma (PDAC) based on our pan-cancer analyses revealing DDR1’s pronounced impact in this malignancy, where it demonstrated the strongest association with immunosuppressive signatures. Here, DDR1 is linked to pancreatic ductal adenocarcinoma.